Stock

L’Oréal to buy South Korean skincare brand Dr.G from Migros – report

Investing.com — L’Oréal (EPA:OREP) on Monday said it has agreed to acquire Gowoonsesang Cosmetics, the company behind the South Korean skincare brand Dr.G, from Swiss retailer Migros, as per a Reuters report. 

This move aligns with L’Oréal’s strategy to expand its footprint in the rapidly growing K-Beauty market, known for its innovation and global appeal.

In a statement, the French cosmetics giant flagged the strong demand for K-Beauty products, emphasizing the affordability and effectiveness of Dr.G’s skincare range. The company noted that Dr.G has potential for growth across Asia and globally, as per the report.

The deal follows Migros’s review of its Mibelle cosmetics unit, announced in February, which sought new ownership for Gowoonsesang and other associated brands. 

While financial details of the transaction were not disclosed, the deal occurs amidst a cooling of China’s previously booming beauty market, the report said.

This marks L’Oréal’s second major investment in South Korea’s beauty sector, following its 2018 acquisition of the makeup brand 3CE.

This post appeared first on investing.com

You May Also Like

Economy

A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

Investing

Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

Editor's Pick

Sen. JD Vance (R-Ohio) and Minnesota Gov. Tim Walz (D) will face off Tuesday night at a CBS News vice-presidential debate in New York....

Latest News

A North Korean defector who escaped to the South more than a decade ago was detained after attempting to cross back into North Korea...

Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 balanceandcharge.com

Exit mobile version